Drug Shortage Report for BENLYSTA
| Report ID | 64584 |
| Drug Identification Number | 02370069 |
| Brand name | BENLYSTA |
| Common or Proper name | belimumab lyophilized powder for intravenous infusion |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BELIMUMAB |
| Strength(s) | 400MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1x20mL |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-10-12 |
| Estimated end date | 2018-10-25 |
| Actual end date | 2018-10-18 |
| Shortage status | Resolved |
| Updated date | 2018-10-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-10-19 | French | Compare |
| v3 | 2018-10-19 | English | Compare |
| v2 | 2018-10-17 | French | Compare |
| v1 | 2018-10-17 | English | Compare |
Showing 1 to 4 of 4